nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—CYP2B6—Sorafenib—thyroid cancer	0.124	0.17	CbGbCtD
Ticlopidine—CYP2C8—Sorafenib—thyroid cancer	0.094	0.128	CbGbCtD
Ticlopidine—CYP2C19—Sorafenib—thyroid cancer	0.0789	0.108	CbGbCtD
Ticlopidine—CYP2B6—Doxorubicin—thyroid cancer	0.0753	0.103	CbGbCtD
Ticlopidine—CYP1A2—Sorafenib—thyroid cancer	0.0728	0.0995	CbGbCtD
Ticlopidine—CYP2C9—Sorafenib—thyroid cancer	0.0656	0.0896	CbGbCtD
Ticlopidine—CYP3A4—Vandetanib—thyroid cancer	0.0633	0.0865	CbGbCtD
Ticlopidine—CYP2D6—Sorafenib—thyroid cancer	0.06	0.082	CbGbCtD
Ticlopidine—CYP3A4—Sorafenib—thyroid cancer	0.0381	0.0521	CbGbCtD
Ticlopidine—CYP2D6—Doxorubicin—thyroid cancer	0.0364	0.0497	CbGbCtD
Ticlopidine—CYP3A4—Doxorubicin—thyroid cancer	0.0231	0.0316	CbGbCtD
Ticlopidine—Nephropathy—Vandetanib—thyroid cancer	0.0122	0.0456	CcSEcCtD
Ticlopidine—Nephrotic syndrome—Sorafenib—thyroid cancer	0.00812	0.0303	CcSEcCtD
Ticlopidine—Tubulointerstitial nephritis—Vandetanib—thyroid cancer	0.0076	0.0283	CcSEcCtD
Ticlopidine—Diarrhoea haemorrhagic—Epirubicin—thyroid cancer	0.00574	0.0214	CcSEcCtD
Ticlopidine—Colitis—Vandetanib—thyroid cancer	0.00559	0.0208	CcSEcCtD
Ticlopidine—Leukaemia—Epirubicin—thyroid cancer	0.00539	0.0201	CcSEcCtD
Ticlopidine—Diarrhoea haemorrhagic—Doxorubicin—thyroid cancer	0.00531	0.0198	CcSEcCtD
Ticlopidine—Tubulointerstitial nephritis—Sorafenib—thyroid cancer	0.00513	0.0191	CcSEcCtD
Ticlopidine—Sepsis—Vandetanib—thyroid cancer	0.00505	0.0188	CcSEcCtD
Ticlopidine—Leukaemia—Doxorubicin—thyroid cancer	0.00498	0.0186	CcSEcCtD
Ticlopidine—Hyponatraemia—Vandetanib—thyroid cancer	0.00424	0.0158	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.00422	0.0157	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00323	0.012	CcSEcCtD
Ticlopidine—Renal failure—Vandetanib—thyroid cancer	0.0032	0.0119	CcSEcCtD
Ticlopidine—Hepatic failure—Sorafenib—thyroid cancer	0.00317	0.0118	CcSEcCtD
Ticlopidine—Haematuria—Vandetanib—thyroid cancer	0.0031	0.0116	CcSEcCtD
Ticlopidine—Epistaxis—Vandetanib—thyroid cancer	0.00307	0.0114	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00302	0.0113	CcSEcCtD
Ticlopidine—Myositis—Epirubicin—thyroid cancer	0.00296	0.011	CcSEcCtD
Ticlopidine—Haemoglobin—Vandetanib—thyroid cancer	0.00294	0.011	CcSEcCtD
Ticlopidine—Haemorrhage—Vandetanib—thyroid cancer	0.00292	0.0109	CcSEcCtD
Ticlopidine—Hyponatraemia—Sorafenib—thyroid cancer	0.00286	0.0107	CcSEcCtD
Ticlopidine—Erythema multiforme—Vandetanib—thyroid cancer	0.00276	0.0103	CcSEcCtD
Ticlopidine—Myositis—Doxorubicin—thyroid cancer	0.00274	0.0102	CcSEcCtD
Ticlopidine—Muscle spasms—Vandetanib—thyroid cancer	0.00245	0.00912	CcSEcCtD
Ticlopidine—Thrombocytosis—Epirubicin—thyroid cancer	0.00233	0.0087	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00218	0.00812	CcSEcCtD
Ticlopidine—Arthralgia—Vandetanib—thyroid cancer	0.00217	0.00807	CcSEcCtD
Ticlopidine—Thrombocytosis—Doxorubicin—thyroid cancer	0.00216	0.00805	CcSEcCtD
Ticlopidine—Renal failure—Sorafenib—thyroid cancer	0.00216	0.00805	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00215	0.00803	CcSEcCtD
Ticlopidine—Bone marrow depression—Epirubicin—thyroid cancer	0.00215	0.00801	CcSEcCtD
Ticlopidine—Epistaxis—Sorafenib—thyroid cancer	0.00207	0.00772	CcSEcCtD
Ticlopidine—Lung disorder—Epirubicin—thyroid cancer	0.00205	0.00764	CcSEcCtD
Ticlopidine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00203	0.00758	CcSEcCtD
Ticlopidine—Bone marrow depression—Doxorubicin—thyroid cancer	0.00199	0.00741	CcSEcCtD
Ticlopidine—Haemoglobin—Sorafenib—thyroid cancer	0.00198	0.00739	CcSEcCtD
Ticlopidine—Haemorrhage—Sorafenib—thyroid cancer	0.00197	0.00735	CcSEcCtD
Ticlopidine—Lung disorder—Doxorubicin—thyroid cancer	0.0019	0.00707	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00189	0.00705	CcSEcCtD
Ticlopidine—Erythema multiforme—Sorafenib—thyroid cancer	0.00186	0.00695	CcSEcCtD
Ticlopidine—Tinnitus—Sorafenib—thyroid cancer	0.00184	0.00685	CcSEcCtD
Ticlopidine—Dyspepsia—Vandetanib—thyroid cancer	0.00183	0.00681	CcSEcCtD
Ticlopidine—Decreased appetite—Vandetanib—thyroid cancer	0.0018	0.00673	CcSEcCtD
Ticlopidine—Pain—Vandetanib—thyroid cancer	0.00178	0.00662	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0017	0.00633	CcSEcCtD
Ticlopidine—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00165	0.00616	CcSEcCtD
Ticlopidine—Muscle spasms—Sorafenib—thyroid cancer	0.00165	0.00615	CcSEcCtD
Ticlopidine—Body temperature increased—Vandetanib—thyroid cancer	0.00164	0.00612	CcSEcCtD
Ticlopidine—Arthropathy—Epirubicin—thyroid cancer	0.0016	0.00595	CcSEcCtD
Ticlopidine—Angioedema—Sorafenib—thyroid cancer	0.00157	0.00585	CcSEcCtD
Ticlopidine—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00153	0.0057	CcSEcCtD
Ticlopidine—Asthenia—Vandetanib—thyroid cancer	0.00149	0.00555	CcSEcCtD
Ticlopidine—Arthropathy—Doxorubicin—thyroid cancer	0.00148	0.0055	CcSEcCtD
Ticlopidine—Pruritus—Vandetanib—thyroid cancer	0.00147	0.00548	CcSEcCtD
Ticlopidine—Arthralgia—Sorafenib—thyroid cancer	0.00146	0.00545	CcSEcCtD
Ticlopidine—Myalgia—Sorafenib—thyroid cancer	0.00146	0.00545	CcSEcCtD
Ticlopidine—Diarrhoea—Vandetanib—thyroid cancer	0.00142	0.0053	CcSEcCtD
Ticlopidine—Anaphylactic shock—Sorafenib—thyroid cancer	0.0014	0.00522	CcSEcCtD
Ticlopidine—Colitis—Epirubicin—thyroid cancer	0.00139	0.00519	CcSEcCtD
Ticlopidine—Dizziness—Vandetanib—thyroid cancer	0.00137	0.00512	CcSEcCtD
Ticlopidine—Thrombocytopenia—Sorafenib—thyroid cancer	0.00137	0.00511	CcSEcCtD
Ticlopidine—Anorexia—Sorafenib—thyroid cancer	0.00133	0.00498	CcSEcCtD
Ticlopidine—Vomiting—Vandetanib—thyroid cancer	0.00132	0.00492	CcSEcCtD
Ticlopidine—Ecchymosis—Epirubicin—thyroid cancer	0.00131	0.00489	CcSEcCtD
Ticlopidine—Rash—Vandetanib—thyroid cancer	0.00131	0.00488	CcSEcCtD
Ticlopidine—Dermatitis—Vandetanib—thyroid cancer	0.00131	0.00488	CcSEcCtD
Ticlopidine—Headache—Vandetanib—thyroid cancer	0.0013	0.00485	CcSEcCtD
Ticlopidine—Colitis—Doxorubicin—thyroid cancer	0.00129	0.00481	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00128	0.00476	CcSEcCtD
Ticlopidine—Sepsis—Epirubicin—thyroid cancer	0.00126	0.00469	CcSEcCtD
Ticlopidine—Nausea—Vandetanib—thyroid cancer	0.00123	0.0046	CcSEcCtD
Ticlopidine—Dyspepsia—Sorafenib—thyroid cancer	0.00123	0.0046	CcSEcCtD
Ticlopidine—Decreased appetite—Sorafenib—thyroid cancer	0.00122	0.00454	CcSEcCtD
Ticlopidine—Ecchymosis—Doxorubicin—thyroid cancer	0.00121	0.00452	CcSEcCtD
Ticlopidine—Diabetes mellitus—Epirubicin—thyroid cancer	0.00121	0.00451	CcSEcCtD
Ticlopidine—Pain—Sorafenib—thyroid cancer	0.0012	0.00447	CcSEcCtD
Ticlopidine—Vascular purpura—Epirubicin—thyroid cancer	0.00118	0.00439	CcSEcCtD
Ticlopidine—Hepatic failure—Epirubicin—thyroid cancer	0.00117	0.00437	CcSEcCtD
Ticlopidine—Sepsis—Doxorubicin—thyroid cancer	0.00116	0.00434	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00115	0.00427	CcSEcCtD
Ticlopidine—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00112	0.00418	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00112	0.00416	CcSEcCtD
Ticlopidine—Urticaria—Sorafenib—thyroid cancer	0.00111	0.00415	CcSEcCtD
Ticlopidine—Body temperature increased—Sorafenib—thyroid cancer	0.00111	0.00413	CcSEcCtD
Ticlopidine—Purpura—Epirubicin—thyroid cancer	0.00109	0.00407	CcSEcCtD
Ticlopidine—Vascular purpura—Doxorubicin—thyroid cancer	0.00109	0.00406	CcSEcCtD
Ticlopidine—Hepatic failure—Doxorubicin—thyroid cancer	0.00108	0.00404	CcSEcCtD
Ticlopidine—Hyponatraemia—Epirubicin—thyroid cancer	0.00106	0.00394	CcSEcCtD
Ticlopidine—Osteoarthritis—Epirubicin—thyroid cancer	0.00105	0.00393	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00105	0.00393	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00103	0.00385	CcSEcCtD
Ticlopidine—Hypersensitivity—Sorafenib—thyroid cancer	0.00103	0.00385	CcSEcCtD
Ticlopidine—Purpura—Doxorubicin—thyroid cancer	0.00101	0.00377	CcSEcCtD
Ticlopidine—Asthenia—Sorafenib—thyroid cancer	0.001	0.00375	CcSEcCtD
Ticlopidine—Pruritus—Sorafenib—thyroid cancer	0.000991	0.00369	CcSEcCtD
Ticlopidine—Hyponatraemia—Doxorubicin—thyroid cancer	0.000978	0.00365	CcSEcCtD
Ticlopidine—Osteoarthritis—Doxorubicin—thyroid cancer	0.000974	0.00363	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000974	0.00363	CcSEcCtD
Ticlopidine—Liver function test abnormal—Epirubicin—thyroid cancer	0.000972	0.00362	CcSEcCtD
Ticlopidine—Diarrhoea—Sorafenib—thyroid cancer	0.000958	0.00357	CcSEcCtD
Ticlopidine—Dizziness—Sorafenib—thyroid cancer	0.000926	0.00345	CcSEcCtD
Ticlopidine—Abdominal distension—Epirubicin—thyroid cancer	0.000916	0.00342	CcSEcCtD
Ticlopidine—Eosinophilia—Epirubicin—thyroid cancer	0.000901	0.00336	CcSEcCtD
Ticlopidine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.0009	0.00335	CcSEcCtD
Ticlopidine—Vomiting—Sorafenib—thyroid cancer	0.00089	0.00332	CcSEcCtD
Ticlopidine—Rash—Sorafenib—thyroid cancer	0.000883	0.00329	CcSEcCtD
Ticlopidine—Dermatitis—Sorafenib—thyroid cancer	0.000882	0.00329	CcSEcCtD
Ticlopidine—Headache—Sorafenib—thyroid cancer	0.000877	0.00327	CcSEcCtD
Ticlopidine—Pancytopenia—Epirubicin—thyroid cancer	0.000864	0.00322	CcSEcCtD
Ticlopidine—Abdominal distension—Doxorubicin—thyroid cancer	0.000848	0.00316	CcSEcCtD
Ticlopidine—Eosinophilia—Doxorubicin—thyroid cancer	0.000834	0.00311	CcSEcCtD
Ticlopidine—Nausea—Sorafenib—thyroid cancer	0.000832	0.0031	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000805	0.003	CcSEcCtD
Ticlopidine—Pancytopenia—Doxorubicin—thyroid cancer	0.0008	0.00298	CcSEcCtD
Ticlopidine—Renal failure—Epirubicin—thyroid cancer	0.000798	0.00297	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000795	0.00297	CcSEcCtD
Ticlopidine—Haematuria—Epirubicin—thyroid cancer	0.000774	0.00288	CcSEcCtD
Ticlopidine—Epistaxis—Epirubicin—thyroid cancer	0.000765	0.00285	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000744	0.00278	CcSEcCtD
Ticlopidine—Renal failure—Doxorubicin—thyroid cancer	0.000738	0.00275	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000736	0.00274	CcSEcCtD
Ticlopidine—Haemoglobin—Epirubicin—thyroid cancer	0.000732	0.00273	CcSEcCtD
Ticlopidine—Haemorrhage—Epirubicin—thyroid cancer	0.000729	0.00272	CcSEcCtD
Ticlopidine—Hepatitis—Epirubicin—thyroid cancer	0.000729	0.00272	CcSEcCtD
Ticlopidine—Haematuria—Doxorubicin—thyroid cancer	0.000716	0.00267	CcSEcCtD
Ticlopidine—Epistaxis—Doxorubicin—thyroid cancer	0.000708	0.00264	CcSEcCtD
Ticlopidine—Erythema multiforme—Epirubicin—thyroid cancer	0.000689	0.00257	CcSEcCtD
Ticlopidine—Tinnitus—Epirubicin—thyroid cancer	0.000679	0.00253	CcSEcCtD
Ticlopidine—Haemoglobin—Doxorubicin—thyroid cancer	0.000677	0.00253	CcSEcCtD
Ticlopidine—Haemorrhage—Doxorubicin—thyroid cancer	0.000674	0.00251	CcSEcCtD
Ticlopidine—Hepatitis—Doxorubicin—thyroid cancer	0.000674	0.00251	CcSEcCtD
Ticlopidine—Erythema multiforme—Doxorubicin—thyroid cancer	0.000637	0.00238	CcSEcCtD
Ticlopidine—Tinnitus—Doxorubicin—thyroid cancer	0.000628	0.00234	CcSEcCtD
Ticlopidine—Flatulence—Epirubicin—thyroid cancer	0.000625	0.00233	CcSEcCtD
Ticlopidine—Muscle spasms—Epirubicin—thyroid cancer	0.00061	0.00227	CcSEcCtD
Ticlopidine—Flatulence—Doxorubicin—thyroid cancer	0.000578	0.00216	CcSEcCtD
Ticlopidine—Muscle spasms—Doxorubicin—thyroid cancer	0.000564	0.0021	CcSEcCtD
Ticlopidine—Myalgia—Epirubicin—thyroid cancer	0.00054	0.00201	CcSEcCtD
Ticlopidine—Arthralgia—Epirubicin—thyroid cancer	0.00054	0.00201	CcSEcCtD
Ticlopidine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000518	0.00193	CcSEcCtD
Ticlopidine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000507	0.00189	CcSEcCtD
Ticlopidine—Arthralgia—Doxorubicin—thyroid cancer	0.0005	0.00186	CcSEcCtD
Ticlopidine—Myalgia—Doxorubicin—thyroid cancer	0.0005	0.00186	CcSEcCtD
Ticlopidine—Anorexia—Epirubicin—thyroid cancer	0.000493	0.00184	CcSEcCtD
Ticlopidine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000479	0.00179	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000472	0.00176	CcSEcCtD
Ticlopidine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000469	0.00175	CcSEcCtD
Ticlopidine—Anorexia—Doxorubicin—thyroid cancer	0.000456	0.0017	CcSEcCtD
Ticlopidine—Dyspepsia—Epirubicin—thyroid cancer	0.000456	0.0017	CcSEcCtD
Ticlopidine—Decreased appetite—Epirubicin—thyroid cancer	0.00045	0.00168	CcSEcCtD
Ticlopidine—Pain—Epirubicin—thyroid cancer	0.000443	0.00165	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000436	0.00163	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000423	0.00158	CcSEcCtD
Ticlopidine—Dyspepsia—Doxorubicin—thyroid cancer	0.000422	0.00157	CcSEcCtD
Ticlopidine—Decreased appetite—Doxorubicin—thyroid cancer	0.000416	0.00155	CcSEcCtD
Ticlopidine—Urticaria—Epirubicin—thyroid cancer	0.000411	0.00153	CcSEcCtD
Ticlopidine—Pain—Doxorubicin—thyroid cancer	0.00041	0.00153	CcSEcCtD
Ticlopidine—Body temperature increased—Epirubicin—thyroid cancer	0.000409	0.00153	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000392	0.00146	CcSEcCtD
Ticlopidine—Hypersensitivity—Epirubicin—thyroid cancer	0.000381	0.00142	CcSEcCtD
Ticlopidine—Urticaria—Doxorubicin—thyroid cancer	0.00038	0.00142	CcSEcCtD
Ticlopidine—Body temperature increased—Doxorubicin—thyroid cancer	0.000379	0.00141	CcSEcCtD
Ticlopidine—Asthenia—Epirubicin—thyroid cancer	0.000371	0.00138	CcSEcCtD
Ticlopidine—Pruritus—Epirubicin—thyroid cancer	0.000366	0.00137	CcSEcCtD
Ticlopidine—Diarrhoea—Epirubicin—thyroid cancer	0.000354	0.00132	CcSEcCtD
Ticlopidine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000353	0.00132	CcSEcCtD
Ticlopidine—Asthenia—Doxorubicin—thyroid cancer	0.000344	0.00128	CcSEcCtD
Ticlopidine—Dizziness—Epirubicin—thyroid cancer	0.000342	0.00128	CcSEcCtD
Ticlopidine—Pruritus—Doxorubicin—thyroid cancer	0.000339	0.00126	CcSEcCtD
Ticlopidine—Vomiting—Epirubicin—thyroid cancer	0.000329	0.00123	CcSEcCtD
Ticlopidine—Diarrhoea—Doxorubicin—thyroid cancer	0.000328	0.00122	CcSEcCtD
Ticlopidine—Rash—Epirubicin—thyroid cancer	0.000326	0.00122	CcSEcCtD
Ticlopidine—Dermatitis—Epirubicin—thyroid cancer	0.000326	0.00122	CcSEcCtD
Ticlopidine—Headache—Epirubicin—thyroid cancer	0.000324	0.00121	CcSEcCtD
Ticlopidine—Dizziness—Doxorubicin—thyroid cancer	0.000317	0.00118	CcSEcCtD
Ticlopidine—Nausea—Epirubicin—thyroid cancer	0.000307	0.00115	CcSEcCtD
Ticlopidine—Vomiting—Doxorubicin—thyroid cancer	0.000304	0.00114	CcSEcCtD
Ticlopidine—Rash—Doxorubicin—thyroid cancer	0.000302	0.00113	CcSEcCtD
Ticlopidine—Dermatitis—Doxorubicin—thyroid cancer	0.000302	0.00112	CcSEcCtD
Ticlopidine—Headache—Doxorubicin—thyroid cancer	0.0003	0.00112	CcSEcCtD
Ticlopidine—Nausea—Doxorubicin—thyroid cancer	0.000284	0.00106	CcSEcCtD
